Sangamo backs up early success for hemophilia gene therapy

Sangamo backs up early success for hemophilia gene therapy

Submitted by admin on July 6, 2019 - 1:36pm
Source: 
Biopharma Dive
News Tags: 
Sangamo
gene therapy
hemophilia A
SB-525
Pfizer
Spark Therapeutics
Biomarin
Headline: 
Sangamo backs up early success for hemophilia gene therapy
snippet: 

Updated results show the highest dose of Sangamo's gene therapy boosted blood-clotting protein levels for hemophilia A patients to normal levels.

Do Not Allow Advertisers to Use My Personal information